Table 2.
Variables | pSS (≤3y) | Non-SS-MGD (≤3y) | pSS (>3y) | Non-SS-MGD (>3y) | |
---|---|---|---|---|---|
Female | 26 | 27 | 23 | 25 | |
Age (years) | 47.26 ± 11.18 | 46.73 ± 11.39 | 51.55 ± 8.86 | 49.91 ± 12.35 | |
Medical history (months) | 17.91 ± 14.21 | 16.97 ± 15.36 | 82.96 ± 30.68 | 80.66 ± 31.72 | |
OSDI | 25.56 ± 10.01 | 19.46 ± 8.44b | 31.73 ± 9.85 | 20.49 ± 7.71b | |
Schirmer I test (mm) | OD | 4.78 ± 0.79 | 7.21 ± 0.91b | 3.11 ± 0.75 | 7.91 ± 0.93b |
OS | 4.80 ± 0.81 | 7.28 ± 0.89b | 3.18 ± 0.69 | 7.98 ± 0.91b | |
BUT (s) | OD | 4.21 ± 2.17 | 6.97 ± 3.79b | 2.31 ± 1.85 | 6.38 ± 3.81b |
OS | 4.19 ± 2.09 | 7.01 ± 3.79b | 2.23 ± 1.72 | 6.09 ± 3.54b | |
CFS (score) | OD | 7.12 ± 5.33 | 4.26 ± 2.15b | 9.31 ± 5.11 | 5.12 ± 2.98b |
OS | 7.09 ± 5.26 | 4.31 ± 3.32b | 9.27 ± 5.37 | 5.11 ± 2.95b | |
TMH (mm) | OD | 0.09 ± 0.10 | 0.13 ± 0.16a | 0.07 ± 0.12 | 0.13 ± 0.19a |
OS | 0.09 ± 0.11 | 0.12 ± 0.18a | 0.07 ± 0.11 | 0.12 ± 0.16a |
Symptoms and DED related examinations in the patients with pSS compared to non-SS-related MGD. Values equal the mean ± SE. DED, dry eye disease; MGD, meibomian gland dysfunction; pSS, primary Sjögren syndrome; OSDI, Ocular Surface Disease Index.
Significantly (ap < 0.05, bp ≤ 0.01) greater than in the controls.